Autor: "Kiely, David" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Pulmonary Hypertension: Intensification and Personalization of Combination Rx (PHoenix): A phase IV randomized trial for the evaluation of dose-response and clinical efficacy of riociguat and selexipag using implanted technologies.
Autorzy:: Varian F; Division of Clinical Medicine University of Sheffield Sheffield UK.; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK.
Dick J; Division of Clinical Medicine University of Sheffield Sheffield UK.
Battersby C; Division of Clinical Medicine University of Sheffield Sheffield UK.
Roman S; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK.
Ablott J; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK.
Watson L; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK.
Binmahfooz S; Division of Clinical Medicine University of Sheffield Sheffield UK.
Zafar H; Division of Clinical Medicine University of Sheffield Sheffield UK.; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK.
Colgan G; Royal Free NHS Foundation Trust London UK.
Cannon J; Royal Papworth Hospital NHS Foundation Trust Cambridge UK.
Suntharalingam J; Royal United Hospitals Bath NHS Foundation Trust Bath UK.
Lordan J; Newcastle Hospitals NHS Foundation Trust Newcastle UK.
Howard L; Imperial College Healthcare NHS Trust London UK.
McCabe C; Royal Brompton and Harefield Guy's and St Thomas' NHS Foundation Trust London UK.
Wort J; NHS Greater Glasgow and Clyde Glasgow UK.
Price L; NHS Greater Glasgow and Clyde Glasgow UK.
Church C; National Heart and Lung Institute, Faculty of Medicine, Imperial College London London UK.
Hamilton N; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK.
Armstrong I; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK.
Hameed A; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK.
Hurdman J; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK.
Elliot C; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK.
Condliffe R; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK.
Wilkins M; National Heart and Lung Institute, Faculty of Medicine, Imperial College London London UK.
Webb A; Wolfson Centre for Prevention of Stroke and Dementia University of Oxford Oxford UK.
Adlam D; Cardiovascular Research Unit of Leicester Leicester UK.
Benza RL; Mount Sinai Heart Icahn School of Medicine at Mount Sinai New York New York USA.
Rahimi K; Deep Medicine, Nuffield Department of Women's and Reproductive Health University of Oxford Oxford UK.
Shojaei-Shahrokhabadi M; Biostatistics Research Group, Population Health Sciences Institute Newcastle University Newcastle upon Tyne UK.
Lin NX; Biostatistics Research Group, Population Health Sciences Institute Newcastle University Newcastle upon Tyne UK.
Wason JMS; Biostatistics Research Group, Population Health Sciences Institute Newcastle University Newcastle upon Tyne UK.
McIntosh A; Robertson Centre for Biostatistics, School of Health and Wellbeing University of Glasgow Glasgow UK.
McConnachie A; Robertson Centre for Biostatistics, School of Health and Wellbeing University of Glasgow Glasgow UK.
Middleton JT; Division of Clinical Medicine University of Sheffield Sheffield UK.; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK.
Thompson R; Division of Clinical Medicine University of Sheffield Sheffield UK.; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK.
Kiely DG; Division of Clinical Medicine University of Sheffield Sheffield UK.; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK.
Toshner M; Department of Medicine, Heart and Lung Research Institute University of Cambridge Cambridge UK.
Rothman A; Division of Clinical Medicine University of Sheffield Sheffield UK.; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK.; Pokaż więcej
Źródło:: Pulmonary circulation [Pulm Circ] 2024 Mar 17; Vol. 14 (1), pp. e12337. Date of Electronic Publication: 2024 Mar 17 (Print Publication: 2024).
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Effect of Macitentan in Pulmonary Arterial Hypertension and the Relationship Between Echocardiography and cMRI Variables: REPAIR Echocardiography Sub-study Results.
Autorzy:: Torbicki A; Department of Pulmonary Circulation, Thromboembolic Disease and Cardiology, Centre for Postgraduate Medical Education ECZ-Otwock, ERN-LUNG Member, F. Chopin Hospital European Health Centre, ul. Borowa 14/18, 05-400, Otwock, Poland. .
Channick R; David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Galiè N; Cardiology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna and Dipartimento DIMES, Università di Bologna, Bologna, Italy.
Kiely DG; Sheffield Pulmonary Vascular Disease Unit, NIHR Biomedical Research Centre Sheffield and University of Sheffield, Sheffield, UK.
Moceri P; Cardiology Department, UR2CA, Pasteur University Hospital, Côte-d'Azur University, Nice, France.
Peacock A; Scottish Pulmonary Vascular Unit, Glasgow, UK.
Swift AJ; Department of Infection, Immunity & Cardiovascular Disease, National Institute for Health and Care Research Sheffield Biomedical Research Centre, University of Sheffield, Sheffield, UK.
Tawakol A; Massachusetts General Hospital and Harvard Medical School, Boston, USA.
Vonk Noordegraaf A; Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Flores D; Actelion Pharmaceuticals Ltd, a Janssen Pharmaceutical Company of Johnson & Johnson, Global Medical Affairs, Allschwil, Switzerland.
Martin N; Actelion Pharmaceuticals Ltd, a Janssen Pharmaceutical Company of Johnson & Johnson, Statistical Decision Science, Allschwil, Switzerland.
Rosenkranz S; Department of Cardiology, Heart Center, University Hospital Cologne, and Cologne Cardiovascular Research Center (CCRC), University of Cologne, Cologne, Germany.; Pokaż więcej
Źródło:: Cardiology and therapy [Cardiol Ther] 2024 Mar; Vol. 13 (1), pp. 173-190. Date of Electronic Publication: 2024 Jan 28.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: A transparent artificial intelligence framework to assess lung disease in pulmonary hypertension.
Autorzy:: Mamalakis M; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Beech Hill Rd, Sheffield, S10 2RX, UK. .; Department of Computer Science, University of Sheffield, 211 Portobello, Sheffield, S1 4DP, UK. .; Insigneo Institute for in silico Medicine, University of Sheffield, The Pam Liversidge Building, Sheffield, S1 3JD, UK. .
Dwivedi K; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Beech Hill Rd, Sheffield, S10 2RX, UK.; Insigneo Institute for in silico Medicine, University of Sheffield, The Pam Liversidge Building, Sheffield, S1 3JD, UK.
Sharkey M; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Beech Hill Rd, Sheffield, S10 2RX, UK.
Alabed S; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Beech Hill Rd, Sheffield, S10 2RX, UK.; Insigneo Institute for in silico Medicine, University of Sheffield, The Pam Liversidge Building, Sheffield, S1 3JD, UK.
Kiely D; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Beech Hill Rd, Sheffield, S10 2RX, UK.; Department of Cardiology, University of Sheffield, Sheffield Teaching Hospitals Sheffield, Sheffield, S5 7AU, UK.
Swift AJ; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Beech Hill Rd, Sheffield, S10 2RX, UK. .; Insigneo Institute for in silico Medicine, University of Sheffield, The Pam Liversidge Building, Sheffield, S1 3JD, UK. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Mar 07; Vol. 13 (1), pp. 3812. Date of Electronic Publication: 2023 Mar 07.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Hypertension, Pulmonary*/diagnostic imaging
Hypertension, Pulmonary*/etiology
Radiographic Image Interpretation, Computer-Assisted*
Lung Diseases*/complications
Lung Diseases*/diagnosis
Humans ; Artificial Intelligence ; Models, Anatomic ; Software ; Tomography, X-Ray Computed/methods ; Lung/diagnostic imaging

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Healthcare resource utilization and quality of life in patients with sarcoidosis-associated pulmonary hypertension.
Autorzy:: Lawrie A; National Heart and Lung Institute, Imperial College London London UK.; Insigneo Institute for In-Silico Medicine University of Sheffield Sheffield UK.
Hamilton N; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital Sheffield UK.
Wood S; Insigneo Institute for In-Silico Medicine University of Sheffield Sheffield UK.; Scientific Computing, Sheffield Teaching Hospitals NHS Foundation Trust Royal Hallamshire Hospital Sheffield UK.
Exposto F; IQVIA London UK.
Muzwidzwa R; IQVIA London UK.
Raiteri L; IQVIA London UK.
Beaudet A; Actelion Pharmaceuticals Ltd. Allschwil Switzerland.
Muller A; Actelion Pharmaceuticals Ltd. Allschwil Switzerland.
Sauter R; Actelion Pharmaceuticals Ltd. Allschwil Switzerland.
Pillai N; Actelion Pharmaceuticals Ltd. Allschwil Switzerland.
Kiely DG; Insigneo Institute for In-Silico Medicine University of Sheffield Sheffield UK.; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital Sheffield UK.; Department of Infection, Immunity and Cardiovascular Disease University of Sheffield Sheffield UK.; Pokaż więcej
Źródło:: Pulmonary circulation [Pulm Circ] 2022 Sep 30; Vol. 12 (4), pp. e12136. Date of Electronic Publication: 2022 Sep 30 (Print Publication: 2022).
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Pulmonary Vascular Research Institute GoDeep: A meta-registry merging deep phenotyping datafrom international PH reference centers.
Autorzy:: Majeed RW; Department of Internal Medicine Universities of Giessen and Marburg Lung Center (UGMLC), German Center for Lung Research (DZL) Giessen Germany.; Institute of Medical Informatics RWTH Aachen University Aachen Germany.
Wilkins MR; National Heart and Lung Institute and Imperial College London NHS Healthcare Trust London UK.
Howard L; National Heart and Lung Institute and Imperial College London NHS Healthcare Trust London UK.
Hassoun PM; Department of Medicine Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine Baltimore Maryland USA.
Anthi A; 1st Department of Critical Care National & Kapodistrian University of Athens Medical School and Pulmonary Hypertension Clinic, Evangelismos General Hospital Athens Greece.
Cajigas HR; Division of Pulmonary and Critical Care Medicine Mayo Clinic Rochester New York USA.
Cannon J; Pulmonary Vascular Diseases Unit, Royal Papworth Hospital, Cambridge Biomedical Campus Cambridge UK.
Chan SY; Department of Medicine, Division of Cardiology, Center for Pulmonary Vascular Biology and Medicine, Pittsburgh Heart, Lung, Blood, and Vascular Medicine Institute University of Pittsburgh School of Medicine and University of Pittsburgh Medical Center Pittsburgh Pennsylvania USA.
Damonte V; Hospital de Niños, Hospital Privado Universitario, Clinica Universitaria Reina Fabiola and Instituto Oulton-Catholic, University of Córdoba Córdoba Argentina.
Elwing J; Division of Pulmonary, Critical Care and Sleep Medicine University of Cincinnati College of Medicine Cincinnati Ohio USA.
Förster K; Ludwig-Maximilians University of Munich Munchen Germany.
Frantz R; Department of Cardiology Mayo Clinic Rochester New York USA.
Ghio S; Fondazione IRCCS Policlinico S.Matteo Pavia Italy.
Al Ghouleh I; Department of Medicine, Division of Cardiology, Center for Pulmonary Vascular Biology and Medicine, Pittsburgh Heart, Lung, Blood, and Vascular Medicine Institute University of Pittsburgh School of Medicine and University of Pittsburgh Medical Center Pittsburgh Pennsylvania USA.
Hilgendorff A; Ludwig-Maximilians University of Munich Munchen Germany.
Jose A; Division of Pulmonary, Critical Care and Sleep Medicine University of Cincinnati College of Medicine Cincinnati Ohio USA.
Juaneda E; Hospital de Niños, Hospital Privado Universitario, Clinica Universitaria Reina Fabiola and Instituto Oulton-Catholic, University of Córdoba Córdoba Argentina.
Kiely DG; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital and University of Sheffield Sheffield UK.
Lawrie A; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital and University of Sheffield Sheffield UK.
Orfanos SE; 1st Department of Critical Care National & Kapodistrian University of Athens Medical School and Pulmonary Hypertension Clinic, Evangelismos General Hospital Athens Greece.
Pepe A; Fondazione IRCCS Policlinico S.Matteo Pavia Italy.
Pepke-Zaba J; Pulmonary Vascular Diseases Unit, Royal Papworth Hospital, Cambridge Biomedical Campus Cambridge UK.
Sirenko Y; Department of Symptomatic Hypertension 'National Scientific Center 'The M.D. Strazhesko Institute of Cardiology'' of National Academy of Medical Science Kyiv Ukraine.
Swett AJ; Division of Pulmonary, Allergy, and Critical Care, and Vera Moulton Wall Center for Pulmonary Vascular Disease Stanford University Stanford California USA.
Torbas O; Department of Symptomatic Hypertension 'National Scientific Center 'The M.D. Strazhesko Institute of Cardiology'' of National Academy of Medical Science Kyiv Ukraine.
Zamanian RT; Division of Pulmonary, Allergy, and Critical Care, and Vera Moulton Wall Center for Pulmonary Vascular Disease Stanford University Stanford California USA.
Marquardt K; Department of Internal Medicine Universities of Giessen and Marburg Lung Center (UGMLC), German Center for Lung Research (DZL) Giessen Germany.
Michel-Backofen A; Department of Internal Medicine Universities of Giessen and Marburg Lung Center (UGMLC), German Center for Lung Research (DZL) Giessen Germany.
Antoine T; Department of Internal Medicine Universities of Giessen and Marburg Lung Center (UGMLC), German Center for Lung Research (DZL) Giessen Germany.
Wilhelm J; Institute for Lung Health (ILH), Cardio-Pulmonary Institute (CPI) Giessen Germany.
Barwick S; Pulmonary Vascular Research Institute (PVRI) Canterbury UK.
Krieb P; Department of Internal Medicine Universities of Giessen and Marburg Lung Center (UGMLC), German Center for Lung Research (DZL) Giessen Germany.
Fuenderich M; Department of Internal Medicine Universities of Giessen and Marburg Lung Center (UGMLC), German Center for Lung Research (DZL) Giessen Germany.
Fischer P; Department of Internal Medicine Universities of Giessen and Marburg Lung Center (UGMLC), German Center for Lung Research (DZL) Giessen Germany.
Gall H; Department of Internal Medicine Universities of Giessen and Marburg Lung Center (UGMLC), German Center for Lung Research (DZL) Giessen Germany.
Ghofrani HA; Department of Internal Medicine Universities of Giessen and Marburg Lung Center (UGMLC), German Center for Lung Research (DZL) Giessen Germany.; Institute for Lung Health (ILH), Cardio-Pulmonary Institute (CPI) Giessen Germany.
Grimminger F; Department of Internal Medicine Universities of Giessen and Marburg Lung Center (UGMLC), German Center for Lung Research (DZL) Giessen Germany.; Institute for Lung Health (ILH), Cardio-Pulmonary Institute (CPI) Giessen Germany.
Tello K; Department of Internal Medicine Universities of Giessen and Marburg Lung Center (UGMLC), German Center for Lung Research (DZL) Giessen Germany.; Institute for Lung Health (ILH), Cardio-Pulmonary Institute (CPI) Giessen Germany.
Richter MJ; Department of Internal Medicine Universities of Giessen and Marburg Lung Center (UGMLC), German Center for Lung Research (DZL) Giessen Germany.; Institute for Lung Health (ILH), Cardio-Pulmonary Institute (CPI) Giessen Germany.
Seeger W; Department of Internal Medicine Universities of Giessen and Marburg Lung Center (UGMLC), German Center for Lung Research (DZL) Giessen Germany.; Institute for Lung Health (ILH), Cardio-Pulmonary Institute (CPI) Giessen Germany.; Pokaż więcej
Źródło:: Pulmonary circulation [Pulm Circ] 2022 Jul 01; Vol. 12 (3), pp. e12123. Date of Electronic Publication: 2022 Jul 01 (Print Publication: 2022).
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Examining the impact of pulmonary hypertension on nonprofessional caregivers: A mixed-methods systematic review.
Autorzy:: Rawlings GH; Psychology Department Nottingham Trent University Nottingham UK.
Beail N; Clinical Psychology Unit University of Sheffield Sheffield UK.
Condliffe R; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK.
Kiely DG; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK.; Department of Infection, Immunity and Cardiovascular Disease University of Sheffield Sheffield UK.
Thompson AR; South Wales Clinical Psychology Training Programme Cardiff and Vale University Health Board & Cardiff University Cardiff UK.
Sabroe I; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK.
Armstrong I; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK.; Pokaż więcej
Źródło:: Pulmonary circulation [Pulm Circ] 2022 Apr 22; Vol. 12 (2), pp. e12077. Date of Electronic Publication: 2022 Apr 22 (Print Publication: 2022).
Typ publikacji:: Journal Article; Review

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Elective lower limb orthopedic arthroplasty surgery in patients with pulmonary hypertension.
Autorzy:: Wardle M; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Trust Sheffield UK.; Department of Anaesthetics Sheffield Teaching Hospitals NHS Trust Sheffield UK.
Nair A; Department of Anaesthetics Sheffield Teaching Hospitals NHS Trust Sheffield UK.
Saunders S; Department of Anaesthetics Sheffield Teaching Hospitals NHS Trust Sheffield UK.
Armstrong I; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Trust Sheffield UK.
Charalampopoulos A; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Trust Sheffield UK.
Elliot C; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Trust Sheffield UK.
Hameed A; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Trust Sheffield UK.; Department of Infection, Immunity and Cardiovascular Disease University of Sheffield Sheffield UK.
Hamilton N; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Trust Sheffield UK.
Harrington J; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Trust Sheffield UK.
Keen C; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Trust Sheffield UK.
Lewis R; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Trust Sheffield UK.; Department of Infection, Immunity and Cardiovascular Disease University of Sheffield Sheffield UK.
Sabroe I; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Trust Sheffield UK.
Thompson AAR; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Trust Sheffield UK.; Department of Infection, Immunity and Cardiovascular Disease University of Sheffield Sheffield UK.
Kerry RM; Department of Orthopaedic Surgery Sheffield Teaching Hospitals NHS Trust Sheffield UK.
Condliffe R; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Trust Sheffield UK.; Department of Infection, Immunity and Cardiovascular Disease University of Sheffield Sheffield UK.
Kiely DG; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Trust Sheffield UK.; Department of Infection, Immunity and Cardiovascular Disease University of Sheffield Sheffield UK.; Pokaż więcej
Źródło:: Pulmonary circulation [Pulm Circ] 2022 Mar 25; Vol. 12 (1), pp. e12019. Date of Electronic Publication: 2022 Mar 25 (Print Publication: 2022).
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Pulmonary Hypertension in Association with Lung Disease: Quantitative CT and Artificial Intelligence to the Rescue? State-of-the-Art Review.
Autorzy:: Dwivedi K; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield S10 2RX, UK.
Sharkey M; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield S10 2RX, UK.; Radiology Department, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield S10 2JF, UK.
Condliffe R; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield S10 2RX, UK.; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield S10 2JF, UK.
Uthoff JM; Department of Computer Science, University of Sheffield, Sheffield S1 4DP, UK.
Alabed S; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield S10 2RX, UK.
Metherall P; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield S10 2RX, UK.; Radiology Department, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield S10 2JF, UK.
Lu H; Department of Computer Science, University of Sheffield, Sheffield S1 4DP, UK.; INSIGNEO, Institute for In Silico Medicine, University of Sheffield, Sheffield S1 3JD, UK.
Wild JM; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield S10 2RX, UK.; INSIGNEO, Institute for In Silico Medicine, University of Sheffield, Sheffield S1 3JD, UK.
Hoffman EA; Advanced Pulmonary Physiomic Imaging Laboratory, University of Iowa, C748 GH, Iowa City, IA 52242, USA.
Swift AJ; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield S10 2RX, UK.; Radiology Department, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield S10 2JF, UK.; INSIGNEO, Institute for In Silico Medicine, University of Sheffield, Sheffield S1 3JD, UK.
Kiely DG; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield S10 2RX, UK.; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield S10 2JF, UK.; INSIGNEO, Institute for In Silico Medicine, University of Sheffield, Sheffield S1 3JD, UK.; Pokaż więcej
Źródło:: Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2021 Apr 09; Vol. 11 (4). Date of Electronic Publication: 2021 Apr 09.
Typ publikacji:: Journal Article; Review

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Current and future treatments of pulmonary arterial hypertension.
Autorzy:: Sommer N; Cardiopulmonary Institute (CPI), University of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Justus-Liebig-University, Giessen, Germany.
Ghofrani HA; Cardiopulmonary Institute (CPI), University of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Justus-Liebig-University, Giessen, Germany.; Department of Medicine, Imperial College London, London, UK.
Pak O; Cardiopulmonary Institute (CPI), University of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Justus-Liebig-University, Giessen, Germany.
Bonnet S; Groupe de recherche en hypertension pulmonaire Centre de recherche de IUCPQ, Universite Laval Quebec, Quebec City, Quebec, Canada.
Provencher S; Groupe de recherche en hypertension pulmonaire Centre de recherche de IUCPQ, Universite Laval Quebec, Quebec City, Quebec, Canada.
Sitbon O; Université Paris-Sud, Faculté de Médecine, Université Paris-Saclay, Le Kremlin-Bicêtre, France. AP-HP, Service de Pneumologie, Hôpital Bicêtre, Le Kremlin-Bicêtre, France. Inserm UMR_S 999, Hôpital Marie-Lannelongue, Le Plessis-Robinson, France.
Rosenkranz S; Klinik III für Innere Medizin, Cologne Cardiovascular Research Center (CCRC), Heart Center at the University of Cologne, Cologne, Germany.
Hoeper MM; Department of Respiratory Medicine, Hannover Medical School, Member of the German Center for Lung Research (DZL), Hanover, Germany.
Kiely DG; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital and Department of Infection Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2021 Jan; Vol. 178 (1), pp. 6-30. Date of Electronic Publication: 2020 Mar 23.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:: Pulmonary Arterial Hypertension*
Humans ; Inflammation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Age-associated changes in 4D flow CMR derived Tricuspid Valvular Flow and Right Ventricular Blood Flow Kinetic Energy.
Autorzy:: Barker N; Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Zafar H; Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Fidock B; Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Elhawaz A; Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Al-Mohammad A; Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Rothman A; Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Kiely DG; Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.; Insigneo Institute for in-silico Medicine, Sheffield, UK.
van der Geest RJ; Cardiovascular Imaging Group, Department of Radiology, Leiden University Medical Centre, Sheffield, UK.
Westenberg J; Cardiovascular Imaging Group, Department of Radiology, Leiden University Medical Centre, Sheffield, UK.
Swift AJ; Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.; Insigneo Institute for in-silico Medicine, Sheffield, UK.
Wild JM; Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.; Insigneo Institute for in-silico Medicine, Sheffield, UK.
Plein S; Division of Biomedical Imaging, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.
Garg P; Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2020 Jun 18; Vol. 10 (1), pp. 9908. Date of Electronic Publication: 2020 Jun 18.
Typ publikacji:: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:: Blood Flow Velocity*
Stroke Volume*
Image Interpretation, Computer-Assisted/*methods
Magnetic Resonance Imaging, Cine/*methods
Tricuspid Valve/*physiology
Ventricular Dysfunction, Right/*physiopathology
Ventricular Function, Right/*physiology
Adult ; Aged ; Aged, 80 and over ; Female ; Follow-Up Studies ; Hemodynamics ; Humans ; Male ; Middle Aged ; Observer Variation ; Prospective Studies ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: A Systematic Review of Right Ventricular Diastolic Assessment by 4D Flow CMR.
Autorzy:: Barker N; Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Fidock B; Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Johns CS; Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Kaur H; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Archer G; Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Rajaram S; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Hill C; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Thomas S; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Karunasaagarar K; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Capener D; Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Al-Mohammad A; Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Rothman A; Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Kiely DG; Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK.
Swift AJ; Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Wild JM; Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Garg P; Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.; Pokaż więcej
Źródło:: BioMed research international [Biomed Res Int] 2019 Mar 14; Vol. 2019, pp. 6074984. Date of Electronic Publication: 2019 Mar 14 (Print Publication: 2019).
Typ publikacji:: Journal Article; Systematic Review
MeSH Terms:: Diastole*
Magnetic Resonance Imaging, Cine*
Ventricular Function, Right*
Heart Ventricles/*diagnostic imaging
Heart Ventricles/*physiopathology
Female ; Humans ; Male

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Diagnostic and prognostic significance of cardiovascular magnetic resonance native myocardial T1 mapping in patients with pulmonary hypertension.
Autorzy:: Saunders LC; POLARIS, Academic Radiology, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Johns CS; POLARIS, Academic Radiology, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Stewart NJ; POLARIS, Academic Radiology, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.; Division of Bioengineering and Bioinformatics, Graduate School of Information Science and Technology, Hokkaido University, Hokudai, Japan.
Oram CJE; POLARIS, Academic Radiology, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Capener DA; POLARIS, Academic Radiology, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Puntmann VO; Institute for Experimental and Translational Cardio Vascular Imaging, University Hospital Frankfurt, Frankfurt, Germany.
Elliot CA; Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK.
Condliffe RC; Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK.
Kiely DG; Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK.; INSIGNEO, Institute for in-silico medicine, Sheffield, UK.
Graves MJ; University of Cambridge School of Clinical Medicine, Cambridge University, Cambridge, UK.
Wild JM; POLARIS, Academic Radiology, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK. .; INSIGNEO, Institute for in-silico medicine, Sheffield, UK. .
Swift AJ; POLARIS, Academic Radiology, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.; INSIGNEO, Institute for in-silico medicine, Sheffield, UK.; Pokaż więcej
Źródło:: Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance [J Cardiovasc Magn Reson] 2018 Dec 03; Vol. 20 (1), pp. 78. Date of Electronic Publication: 2018 Dec 03.
Typ publikacji:: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Hypertension, Pulmonary/*diagnostic imaging
Image Interpretation, Computer-Assisted/*methods
Magnetic Resonance Imaging, Cine/*methods
Adult ; Aged ; Aged, 80 and over ; Disease Progression ; Female ; Hemodynamics ; Humans ; Hypertension, Pulmonary/mortality ; Hypertension, Pulmonary/physiopathology ; Male ; Middle Aged ; Predictive Value of Tests ; Prognosis ; Retrospective Studies ; Ventricular Function, Left ; Ventricular Function, Right ; Ventricular Remodeling

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Autologous haematopoietic stem cell transplantation (aHSCT) for severe resistant autoimmune and inflammatory diseases - a guide for the generalist.
Autorzy:: Snowden JA; Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK .
Sharrack B; Department of Neurology, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.
Akil M; Department of Rheumatology, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.
Kiely DG; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.
Lobo A; Department of Gastroenterology, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.
Kazmi M; Kings Healthcare Partners, London, UK.
Muraro PA; Brain Sciences, Imperial College London, London, UK.
Lindsay JO; Centre for Immunobiology, Barts and the London School of Medicine and Dentistry, Blizard Institute, Queen Mary University of London, London, UK.; Pokaż więcej
Źródło:: Clinical medicine (London, England) [Clin Med (Lond)] 2018 Aug; Vol. 18 (4), pp. 329-334.
Typ publikacji:: Journal Article
MeSH Terms:: Hematopoietic Stem Cell Transplantation*
Transplantation, Autologous*
Autoimmune Diseases/*therapy
Crohn Disease/therapy ; Humans ; Multiple Sclerosis/therapy ; Rheumatic Diseases/therapy

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: A social-technological epistemology of clinical decision-making as mediated by imaging.
Autorzy:: van Baalen S; Department of Philosophy, University of Twente, Enschede, The Netherlands.
Carusi A; Medical School, University of Sheffield, Sheffield, UK.
Sabroe I; Department of Infection Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Kiely DG; University of Sheffield, Sheffield, UK.; Pokaż więcej
Źródło:: Journal of evaluation in clinical practice [J Eval Clin Pract] 2017 Oct; Vol. 23 (5), pp. 949-958. Date of Electronic Publication: 2016 Oct 03.
Typ publikacji:: Journal Article
MeSH Terms:: Clinical Decision-Making*
Group Processes*
Knowledge*
Hypertension, Pulmonary/*diagnosis
Hypertension, Pulmonary/*therapy
Communication ; Decision Making ; Health Knowledge, Attitudes, Practice ; Humans ; Hypertension, Pulmonary/diagnostic imaging ; Interprofessional Relations ; Patient Care Team/organization & administration ; Specialization

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Right ventricular sex differences in patients with idiopathic pulmonary arterial hypertension characterised by magnetic resonance imaging: pair-matched case controlled study.
Autorzy:: Swift AJ; Department of Cardiovascular Science, University of Sheffield, Sheffield, United Kingdom; INSIGNEO, Institute for In Silico Medicine, University of Sheffield, Sheffield, United Kingdom.
Capener D; Department of Cardiovascular Science, University of Sheffield, Sheffield, United Kingdom.
Hammerton C; Department of Cardiovascular Science, University of Sheffield, Sheffield, United Kingdom.
Thomas SM; Radiology Department, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
Elliot C; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
Condliffe R; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
Wild JM; Department of Cardiovascular Science, University of Sheffield, Sheffield, United Kingdom; INSIGNEO, Institute for In Silico Medicine, University of Sheffield, Sheffield, United Kingdom.
Kiely DG; INSIGNEO, Institute for In Silico Medicine, University of Sheffield, Sheffield, United Kingdom; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2015 May 21; Vol. 10 (5), pp. e0127415. Date of Electronic Publication: 2015 May 21 (Print Publication: 2015).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Magnetic Resonance Imaging*
Familial Primary Pulmonary Hypertension/*pathology
Familial Primary Pulmonary Hypertension/*physiopathology
Heart Ventricles/*pathology
Heart Ventricles/*physiopathology
Adult ; Aged ; Case-Control Studies ; Familial Primary Pulmonary Hypertension/diagnosis ; Familial Primary Pulmonary Hypertension/mortality ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Organ Size ; Sex Factors ; Stroke Volume

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Elevated plasma CXCL12α is associated with a poorer prognosis in pulmonary arterial hypertension.
Autorzy:: McCullagh BN; School of Medicine and Medical Science, UCD Conway Institute, University College Dublin, Dublin 4, Ireland; Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin 7, Ireland.
Costello CM; School of Medicine and Medical Science, UCD Conway Institute, University College Dublin, Dublin 4, Ireland.
Li L; School of Medicine and Medical Science, UCD Conway Institute, University College Dublin, Dublin 4, Ireland.
O'Connell C; School of Medicine and Medical Science, UCD Conway Institute, University College Dublin, Dublin 4, Ireland; Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin 7, Ireland.
Codd M; School of Public Health, Physiotherapy and Population Science, University College Dublin, Dublin 4, Ireland.
Lawrie A; Department of Cardiovascular Sciences, University of Sheffield, Sheffield, United Kingdom.
Morton A; Department of Cardiology, Northern General Hospital, Sheffield, United Kingdom.
Kiely DG; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, United Kingdom.
Condliffe R; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, United Kingdom.
Elliot C; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, United Kingdom.
McLoughlin P; School of Medicine and Medical Science, UCD Conway Institute, University College Dublin, Dublin 4, Ireland.
Gaine S; Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin 7, Ireland.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2015 Apr 09; Vol. 10 (4), pp. e0123709. Date of Electronic Publication: 2015 Apr 09 (Print Publication: 2015).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Prognosis*
Chemokine CXCL12/*blood
Familial Primary Pulmonary Hypertension/*blood
Adult ; Aged ; Blood Pressure ; Familial Primary Pulmonary Hypertension/epidemiology ; Familial Primary Pulmonary Hypertension/pathology ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Proportional Hazards Models ; Pulmonary Artery/metabolism ; Pulmonary Artery/pathology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Pregnancy and pulmonary hypertension: a practical approach to management.
Autorzy:: Kiely DG; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield.
Condliffe R; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield.
Wilson VJ; Department of Anaesthesia, Jessop Wing, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield.
Gandhi SV; Department of Obstetrics and Gynaecology, Jessop Wing, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield.
Elliot CA; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield.; Pokaż więcej
Źródło:: Obstetric medicine [Obstet Med] 2013 Dec; Vol. 6 (4), pp. 144-54. Date of Electronic Publication: 2013 Aug 08.
Typ publikacji:: Journal Article; Review

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Diagnostic accuracy of cardiovascular magnetic resonance imaging of right ventricular morphology and function in the assessment of suspected pulmonary hypertension results from the ASPIRE registry.
Autorzy:: Swift AJ; National Institute of Health Research, Cardiovascular Biomedical Research Unit, Sheffield, UK. />Rajaram S
Condliffe R
Capener D
Hurdman J
Elliot CA
Wild JM
Kiely DG; Pokaż więcej
Źródło:: Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance [J Cardiovasc Magn Reson] 2012 Jun 21; Vol. 14, pp. 40. Date of Electronic Publication: 2012 Jun 21.
Typ publikacji:: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Registries*
Ventricular Function, Right*
Heart Ventricles/*pathology
Hypertension, Pulmonary/*diagnosis
Magnetic Resonance Imaging, Cine/*methods
Cardiac Catheterization ; Echocardiography ; Female ; Follow-Up Studies ; Heart Ventricles/diagnostic imaging ; Heart Ventricles/physiopathology ; Humans ; Hypertension, Pulmonary/physiopathology ; Male ; Middle Aged ; ROC Curve ; Reproducibility of Results ; Retrospective Studies ; Stroke Volume

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Kiely, David"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język